These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12837478)

  • 1. Intravenous itraconazole emulsions produced by SolEmuls technology.
    Akkar A; Müller RH
    Eur J Pharm Biopharm; 2003 Jul; 56(1):29-36. PubMed ID: 12837478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilizing poorly soluble antimycotic agents by emulsification via a solvent-free process.
    Akkar A; Namsolleck P; Blaut M; Müller RH
    AAPS PharmSciTech; 2004 Apr; 5(1):E24. PubMed ID: 15198542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of intravenous carbamazepine emulsions by SolEmuls technology.
    Akkar A; Müller RH
    Eur J Pharm Biopharm; 2003 May; 55(3):305-12. PubMed ID: 12754005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs.
    Müller RH; Schmidt S; Buttle I; Akkar A; Schmitt J; Brömer S
    Int J Pharm; 2004 Jan; 269(2):293-302. PubMed ID: 14706241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesophase and size manipulation of itraconazole liquid crystalline nanoparticles produced via quasi nanoemulsion precipitation.
    Mugheirbi NA; Tajber L
    Eur J Pharm Biopharm; 2015 Oct; 96():226-36. PubMed ID: 26264714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption.
    Hong JY; Kim JK; Song YK; Park JS; Kim CK
    J Control Release; 2006 Jan; 110(2):332-338. PubMed ID: 16297483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of parenteral microemulsion containing itraconazole.
    Rhee YS; Park CW; Nam TY; Shin YS; Chi SC; Park ES
    Arch Pharm Res; 2007 Jan; 30(1):114-23. PubMed ID: 17328251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention.
    Duret C; Merlos R; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Eur J Pharm Biopharm; 2014 Jan; 86(1):46-54. PubMed ID: 23523546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization.
    Ye G; Wang S; Heng PW; Chen L; Wang C
    Int J Pharm; 2007 Jun; 337(1-2):80-7. PubMed ID: 17241757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laponite-based nanohybrid for enhanced solubility and controlled release of itraconazole.
    Jung H; Kim HM; Choy YB; Hwang SJ; Choy JH
    Int J Pharm; 2008 Feb; 349(1-2):283-90. PubMed ID: 17888597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanonized itraconazole powders for extemporary oral suspensions: Role of formulation components studied by a mixture design.
    Foglio Bonda A; Rinaldi M; Segale L; Palugan L; Cerea M; Vecchio C; Pattarino F
    Eur J Pharm Sci; 2016 Feb; 83():175-83. PubMed ID: 26742430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats.
    Kumar N; Shishu
    Eur J Pharm Sci; 2015 Jan; 67():97-112. PubMed ID: 25445834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions.
    Shekunov BY; Chattopadhyay P; Seitzinger J; Huff R
    Pharm Res; 2006 Jan; 23(1):196-204. PubMed ID: 16307386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of process parameters on nanoemulsion droplet size and distribution in SPG membrane emulsification.
    Oh DH; Balakrishnan P; Oh YK; Kim DD; Yong CS; Choi HG
    Int J Pharm; 2011 Feb; 404(1-2):191-7. PubMed ID: 21055456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality by design: characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology.
    Shah RB; Zidan AS; Funck T; Tawakkul MA; Nguyenpho A; Khan MA
    Int J Pharm; 2007 Aug; 341(1-2):189-94. PubMed ID: 17521836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of β-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug.
    Sayed S; Elsayed I; Ismail MM
    Int J Pharm; 2018 Oct; 549(1-2):249-260. PubMed ID: 30077759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery.
    Mohanty B; Majumdar DK; Mishra SK; Panda AK; Patnaik S
    Pharm Dev Technol; 2015 Jun; 20(4):458-64. PubMed ID: 24490828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.